Schwenksville, PA, United States of America

Christopher J Dinsmore

This inventor holds 52 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 20 EPO patents, primarily in Kinase Inhibitors (CPC class C07D). Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp., Forma Therapeutics, Inc.. Active years: 1997-2022.

USPTO Granted Patents = 52 (Patent Applications = 4)

% Patents Active = 78.8

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 20 (Patent Applications = 8)

Average Co-Inventor Count = 3.6

ph-index = 13

Forward Citations = 753(Granted Patents)

Forward Citations (Not Self Cited) = 741(Dec 10, 2025)

Inventors with similar research interests:

Location History:

North Wales, PA (US) (1997 - 2000)
Schwenksville, PA (US) (1998 - 2011)
Newton, MA (US) (2009 - 2022)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

2 out of 125

Forma Therapeutics, Inc.

patents

Years Active: 1997-2022

Loading Chart...

Areas of Expertise:

Janus Kinase Inhibitors

Tyrosine Kinase Inhibitors

Farnesyl-Protein Transferase

Acyclic Cyanoethylpyrazolo Pyridones

Cycloalkyl Nitrile

Pyrrolopyrimidines

Isoquinolinone

Potassium Channel Inhibitors

Phenyl-Protein Transferase

Substituted Imidazole Compounds

Bicyclic Diamines

HDM2 Inhibitors

52 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11299484 - Inhibiting fatty acid synthase (FASN) (2022-04-12),

2. 10875848 - Inhibiting fatty acid synthase (FASN) (2020-12-29),

3. 10072025 - Ethyl N-boc piperidinyl pyrazolo pyridones as Janus kinase inhibitors (2018-09-11),

4. 10059705 - Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors (2018-08-28),

5. 9957265 - N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitors (2018-05-01),

6. 9725445 - Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitors (2017-08-08),

7. 9637493 - Substituted pyrrolopyrimidines as HDM2 inhibitors (2017-05-02),

8. 9540377 - 2,6,7,8 substituted purines as HDM2 inhibitors (2017-01-10),

9. 9096598 - Azaindoles as Janus kinase inhibitors (2015-08-04),

10. 8993756 - Pyrrolopyrimidines as janus kinase inhibitors (2015-03-31),

11. 8962608 - Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors (2015-02-24),

12. 8937077 - Bicyclic diamines as janus kinase inhibitors (2015-01-20),

13. 8329722 - Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1 (2012-12-11),

14. 8222269 - Tyrosine kinase inhibitors (2012-07-17),

15. 8101603 - Tyrosine kinase inhibitors (2012-01-24),

Title: The Inventive Mind of Christopher J Dinsmore

Introduction: Christopher J Dinsmore is a renowned inventor based in Schwenksville, PA (US) known for his innovative contributions to various industries.

Latest Patents: Christopher J Dinsmore holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Christopher J Dinsmore has been instrumental in developing cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Christopher J Dinsmore has collaborated with leading companies, research institutions, and universities to bring his inventions to life and make a lasting impact on society.

Conclusion: Christopher J Dinsmore's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.